Cargando…

The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system.

A total of 301 colorectal carcinoma (CRC) archival samples were analysed using the amplification-refractory mutation system (ARMS). Each sample was examined to determine the mutation status of codons 12 and 13 of the K-ras oncogene. The results from direct DNA sequence analysis carried out on 30 of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, J. C., England, J., White, P., Ellison, G., Callaghan, K., Charlesworth, N. R., Hehir, J., McCarthy, T. L., Smith-Ravin, J., Talbot, I. C., Snary, D., Northover, J. M., Newton, C. R., Little, S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150152/ https://www.ncbi.nlm.nih.gov/pubmed/9579832

Ejemplares similares

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
por: Andreyev, H J N, et al.
Publicado: (2001)

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort
por: O’Sullivan, J. M., et al.
Publicado: (2023)

Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
por: Lin, S. R., et al.
Publicado: (1998)

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2018)

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
por: Miller, Mark Steven, et al.
Publicado: (2012)

Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas.
por: Sheng, Z. M., et al.
Publicado: (1990)

Amplification refractory mutation system PCR assays for the detection of variola and Orthopoxvirus
por: Pulford, David, et al.
Publicado: (2004)

Combining the amplification refractory mutation system and high-resolution melting analysis for KRAS mutation detection in clinical samples
por: Oliveira, Beatriz B., et al.
Publicado: (2023)

Sensitive detection of BRAF V600E mutation by Amplification Refractory Mutation System (ARMS)-PCR
por: Huang, Tiangui, et al.
Publicado: (2013)

Tetra-Primer Amplification-Refractory Mutation System (ARMS)—PCR for Genotyping Mouse Leptin Gene Mutation
por: Chen, Jiangang, et al.
Publicado: (2022)

Mutational status of K- ras and TP53 genes in primary sarcomas of the heart
por: Garcia, J M, et al.
Publicado: (2000)

KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab
por: Bando, H, et al.
Publicado: (2011)

No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited.
por: Mooy, C. M., et al.
Publicado: (1991)

c-Ki-ras amplification in human lung cancer.
por: Heighway, J., et al.
Publicado: (1986)

Detecting fa leptin receptor mutation in Zucker rats with tetra-primer amplification-refractory mutation system (ARMS)-PCR
por: Xu, Xinyun, et al.
Publicado: (2023)

K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines
por: Yeung, Yvonne, et al.
Publicado: (2017)

Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer
por: Macedo, F, et al.
Publicado: (2022)

Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma
por: Benoit, Alexandre, et al.
Publicado: (2022)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

RAS Mutation in Mucinous Carcinoma of the Ovary
por: Panyavaranant, Pinyada, et al.
Publicado: (2019)

Mutations of RAS genes in endometrial polyps
por: Takeda, Takashi, et al.
Publicado: (2019)

Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis
por: Ahmad, I, et al.
Publicado: (2011)

Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
por: Smith, G, et al.
Publicado: (2010)

Ras protein abundance correlates with Ras isoform mutation patterns in cancer
por: Hood, Fiona E., et al.
Publicado: (2023)

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
por: Grasselli, J, et al.
Publicado: (2017)

The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck.
por: Clark, L. J., et al.
Publicado: (1993)

Activation of K-RAS by co-mutation of codons 19 and 20 is transforming
por: Naguib, Adam, et al.
Publicado: (2011)

Amplification Refractory Mutation System (ARMS)-PCR for Waxy Sorghum Authentication with Single-Nucleotide Resolution
por: Zhu, Xiaoying, et al.
Publicado: (2021)

Somatic Activating RAS Mutations Cause Vascular Tumors Including Pyogenic Granuloma
por: Lim, Young H., et al.
Publicado: (2015)

Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds.
por: Sutherland, C., et al.
Publicado: (1986)

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
por: Janku, Filip, et al.
Publicado: (2011)

Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas
por: Jones, S, et al.
Publicado: (2004)

Point mutation at codon 12 of the c-Ha-ras gene in human gastric cancers.
por: Koh, E. H., et al.
Publicado: (1992)

Kinetic Hairpin Oligonucleotide Blockers for Selective Amplification of Rare Mutations
por: Jia, Yanwei, et al.
Publicado: (2014)

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
por: Vidal, J, et al.
Publicado: (2017)

Infrequent ras Mutation in Human Stomach Cancers
por: Koshiba, Masahiro, et al.
Publicado: (1993)

Analysis of correlated mutations in Ras G-domain
por: Pathak, Ekta
Publicado: (2017)

Fast simultaneous detection of K-RAS mutations in colorectal cancer
por: Chang, Ya-Sian, et al.
Publicado: (2009)

c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis.
por: Bell, S. M., et al.
Publicado: (1991)

Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
por: Gray, I. C., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_cnevuefc5sr1rulq5qfl8cncf2